4//SEC Filing
NABI BIOPHARMACEUTICALS 4
Accession 0001278819-05-000026
$VXRTCIK 0000072444operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:31 PM ET
Size
5.2 KB
Accession
0001278819-05-000026
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Purchase
Common Stock
2005-05-20$12.17/sh+1,000$12,170→ 3,630.676 total
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:31 PM ET
- Size
- 5.2 KB